Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Should You Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down before the market opened on Friday. The stock had previously closed at $8.87, but opened at $8.26. Curaleaf shares last traded at $8.15, with a volume of 3,628 shares.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CURLF shares. Citigroup restated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. UBS Group set a $6.00 price objective on Curaleaf in a research note on Monday, October 5th. Finally, Zacks Research downgraded shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $6.00.

Curaleaf Price Performance

The firm has a 50 day simple moving average of $9.44 and a 200-day simple moving average of $8.35. The company has a quick ratio of 0.78, a current ratio of 1.61 and a debt-to-equity ratio of 1.09. The company has a market cap of $1.83 billion, a PE ratio of -196.25 and a beta of 1.62.

Curaleaf (OTCMKTS:CURLF) last issued its earnings results on Tuesday, November 3rd. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02. The firm had revenue of $352.65 million for the quarter, compared to analyst estimates of $346.46 million. Curaleaf had a positive return on equity of 0.43% and a negative net margin of 0.76%. As a group, research analysts predict that Curaleaf Holdings, Inc. will post 0.06 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc. is a cannabis company that cultivates, processes and sells cannabis products for medical and adult-use markets. Its products include cannabis flower, pre-rolls, concentrates, vapes, edibles, tinctures and topical products, sold under brands including Curaleaf, Select and Grassroots. The company operates across multiple U.S. markets through cultivation and processing facilities, wholesale operations and retail dispensaries. Through Curaleaf International, it also serves medical cannabis markets in Europe and other international markets.